Barcelona-based biotech Ona Therapeutics raised $86.6M in a Series B round to develop antibody-drug conjugates for cancer treatment.
Amount Raised
$86.6 Million
Round Type
Series B
BarcelonaBiotechnologyTherapeuticsInvestors
Description
Ona Therapeutics has successfully completed an $86.6 million Series B funding round. The funds will be used to advance two antibody-drug conjugates aimed at treating breast and colorectal cancers. CEO Valerie Vanhooren highlights their focus on targeting drug-resistant cancer cells. This innovative approach aims to improve the quality of life for patients who have not responded to other treatments.
Quick answer
Ona Therapeutics raised $86.6 Million in a Series B round, dated June 4, 2026. Investors: Bpifrance, Asabys Partners, Alta Life Sciences, Korys, Cofides, Mérieux Equity Partners and Columbus Venture Partners. Ona Therapeutics is based in Barcelona, Catalonia, Spain.
- How much did Ona Therapeutics raise?
- Ona Therapeutics raised $86.6 Million in a Series B round on June 4, 2026.
- Who invested in Ona Therapeutics?
- Bpifrance, Asabys Partners, Alta Life Sciences, Korys, Cofides, Mérieux Equity Partners and Columbus Venture Partners are named as investors in this round.
- What does Ona Therapeutics do?
- Ona Therapeutics is a global biotech company pioneering first-in-class antibody-drug conjugates (ADCs) to eliminate hard-to-treat, resistant cancer cells.
- Where is Ona Therapeutics based and how big is it?
- Ona Therapeutics is based in Barcelona, Catalonia, Spain.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Ona Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- ME Therapeutics Holdings raised $457K (Post-IPO Equity) on July 17, 2026.
- Sightera Biosciences raised $3.4M (Pre-Seed) on July 17, 2026.
- Georgiamune raised $93M on July 16, 2026.
- Crescent Biopharma raised $8.1M (Post-IPO Equity) on July 15, 2026.
- AdvanCell raised $315M (Series D) on July 15, 2026.
- Draig Therapeutics raised $65M (Series B) on July 14, 2026.
Who to call at Ona Therapeutics, and when
A new round usually means Ona Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ona Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ona Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ona Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ona Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansOna Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.